FDA Adverse Event
Injury
Summary report: N
RAINDROP INLAY
MDR report key: 13500072
·
Received February 8, 2022
Report
- Report Number
- MW5107324
- Event Type
- Injury
- Date Received
- February 8, 2022
- Report Date
- February 6, 2022
- Manufacturer
- REVISION OPTICS / RVO 2.0, INC.
- Product Code
- LQE
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- FL, US
- Reporter Occupation
- PATIENT
- Health Professional
- *
Narratives
Description of Event or Problem · 0
RAINDROP INLAY IN-PLANTED ON OR ABOUT (B)(6) 2018; 6 MONTHS LATER WAS NO LONGER AFFECTIVE. REMOVED (B)(6) 2022. NOW I HAVE PERMANENT BLURRED VISION. FDA SAFETY REPORT ID # (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 757350 | RAINDROP INLAY | IMPLANT, CORNEAL, REFRACTIVE | LQE | REVISION OPTICS / RVO 2.0, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 48 YR | Male | Disability| O | ATORVASTATIN| FISH OIL| GLIPIZIDE| JANUMET| LATANOPROST |